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        T regulatory cells (T reg cells) function to tem-
per the massive proinfl  ammatory stimulus created 
by commensal bacteria within the gut. Evidence 
of their functional importance in suppressing 
gut infl  ammation is observed by the fact that 
their absence permits the onset of gut auto-
immunity (  1, 2  ). Therefore, manipulation of 
T reg cell function within the gut provides an 
attractive therapeutic approach in enforcing gut 
tolerance during times when the balance is shifted 
toward autoimmunity. 
  The ability of activated T cells to exit the 
blood and enter diff  erent tissues of the body is 
  “  imprinted  ”   on them within the secondary lym-
phoid organs by DCs (  3, 4  ). T cells homing to the 
small intestine lamina propria express the integrin 
    4    7, which binds mucosal addressin cell adhe-
sion molecule  –  1 and CC chemokine receptor 
(CCR) 9, whose ligand is secreted within the 
lamina propria (  5  –  8  ). A population of CD103     
DCs that primarily resides within the lamina 
propria, Peyer  ’  s patches, and mesenteric lymph 
nodes are responsible for imprinting a gut-homing 
capacity on T cells by an all-trans retinoic acid 
(RA)  –  dependent mechanism (  1, 9  –  11  ). 
  It has been shown that CD4    FoxP3    −    naive 
T cells can be converted into CD4    FoxP3     
T reg cells (i.e., adaptive T reg cells [A-Tregs]) 
exhibiting the same suppressive and phenotypic 
characteristics as thymically derived, natural T reg 
cells (nTregs) both in vivo and in vitro (  12  –  16  ). 
This conversion is dependent on TGF-    1 and 
requires IL-2 in vitro (  13, 17, 18  ). The use of 
A-Tregs as a means of inducing tolerance has 
been demonstrated in numerous settings, in-
cluding infl  ammatory bowel disease and allo-
transplantation models ( 12, 15, 16, 19 ). Improving 
the potency of A-Treg treatments is of great 
clinical interest, and harnessing imprinting mech-
anisms to target A-Tregs to a specifi  c organ is one 
means to this end. 
  In this report, we use RA to generate a uni que 
population of A-Tregs in vitro that is able to 
home in vivo to the small intestine lamina propria. 
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  We demonstrate that all-trans retinoic acid (RA) induces FoxP3     adaptive T regulatory 
cells (A-Tregs) to acquire a gut-homing phenotype (     4     7      CC chemokine receptor 9     ) 
and the capacity to home to the lamina propria of the small intestine. Under conditions 
that favor the differentiation of A-Tregs (transforming growth factor  –       1 and interleukin 2) 
in vitro, the inclusion of RA induces nearly all activated CD4      T cells to express FoxP3 and 
greatly increases the accumulation of these cells. In the absence of RA, A-Treg differen-
tiation is abruptly impaired by profi  cient antigen presenting cells or through direct 
co-stimulation. In the presence of RA, A-Treg generation occurs even in the presence 
of high levels of co-stimulation, with RA attenuating co-stimulation from interfering 
from FoxP3 induction. The recognition that RA induces gut imprinting, together with our 
fi  nding that it enhances A-Treg conversion, differentiation, and expansion, indicates that 
RA production in vivo may drive both the imprinting and A-Treg development in the face 
of overt infl  ammation. 1766 THE GENERATION OF GUT-HOMING ADAPTIVE T REGULATORY CELLS | Benson et al.
    RESULTS AND DISCUSSION   
  RA synergizes with TGF-     1 to generate A-Tregs 
that home to the small intestine in vivo and express 
suppressive activity 
  RA induces     4    7 and CCR9 expression on CD4     T cells 
during in vitro activation (  11  ). As A-Tregs can be gener-
ated from naive CD4    FoxP3        cells in vitro during stimu-
lation in the presence of TGF-    1 and IL-2, we addressed 
whether CD4    FoxP3        T cells cultured with TGF-    1, RA, 
Surprisingly, RA potently synergized with TGF-   1 in driving 
FoxP3 induction. In addition to increasing the frequency and 
durability of these A-Tregs, RA also allowed FoxP3 expres-
sion to occur in the presence of high levels of co-stimulation, 
levels that normally prevent FoxP3 induction. These experi-
ments highlight the central importance of RA in serving two 
roles: driving gut homing and permitting the development 
of A-Tregs in the presence of overt infl  ammation. These data 
im  plicate RA as a mediator of gut tolerance in vivo. 
  Figure 1.     RA synergizes with TGF-    1 in the generation of gut-homing A-Tregs in vitro. (A and B) FACS-sorted CD4   Foxp3       cells from the Foxp3/
GFP reporter mouse were cultured under activating conditions with IL-2 and TGF-   1      10 nM RA, and surface phenotype and Foxp3/GFP expression was 
analyzed by fl  ow cytometry after 5 d of culture. (A) Representative staining showing the percentage of Foxp3/GFP expression against CD25, CD62L,    4  7, 
CCR9, and CD103. (B) Representative FACS plot depicting Foxp3/GFP expression by CD4     T cells. (C) Quantifi  cation of one representative experiment 
showing the percentage of Foxp3/GFP     cells among all CD4     cells, with the selective RA receptor antagonist LE540 (1     M) included as indicated. Mean  
SEM is shown. (D) Foxp3/GFP expression by CD4     cells as a function of titrating concentrations of TGF-   1      RA. IL-2 concentrations were kept constant, 
    RA, with TGF-    1 (20 ng/ml, 10 ng/ml, 5 ng/ml, 1 ng/ml, and 0) titrated. (E) TGF-      –  mediated Foxp3/GFP expression as a result of titrating concentrations 
of RA. Keeping IL-2 and TGF-    1 constant, RA was titrated in serial dilutions (100 nM, 10 nM, 1 nM, 100 pM, 10 pM, 1 pM, and 0). All experiments shown 
are representative of at least   n   = 3 independent experiments. JEM VOL. 204, August 6, 2007  1767
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Ly5.2    FoxP3/GFP reporter mouse. Sorted CD4    CD25        
cells from a Ly5.2     mouse that did not contain the FoxP3/
GFP knock-in allele were used to generate a population of 
A-Tregs. As the A-Tregs were generated from mice lacking 
the FoxP3/GFP allele, it was impossible to sort them to pu-
rity after inducing FoxP3 expression in vitro, and thus, the 
A-Treg population used contained a substantial percentage 
of FoxP3        cells (unpublished data). However, this does not 
diminish the utility of these cells in an in vivo competitive 
homing experiment. RA  –  T reg cells and A-Tregs were 
equally mixed and injected intravenously into recipient Ly5.1     
mice, and various organs were analyzed for donor cells after 
18 h (  Fig. 2 C  ). After at least 18 h, we did not observe rever-
sion of CD4    FoxP3     RA –  T reg cells to a CD4    FoxP3        pheno-
type in vivo (see   Fig. 5 A  ). As expected from their phenotype, 
the RA  –  T reg cells had the capacity to home to the small 
intestine lamina propria and were in the minority compared 
with A-Tregs in the blood and lung (  Fig. 2 D  ). There was 
also an accumulation of RA  –  T reg cells in the mesenteric 
lymph nodes and the Peyer  ’  s patches. Collectively, these data 
show that functionally suppressive T reg cells with a gut-
homing phenotype can be generated from CD4    FoxP3        T cells 
in vitro, and this cell population has the capacity to home to 
the small intestine in vivo. 
  Co-stimulation and A-T reg cell generation: RA allows DCs 
to drive TGF-     1  –  mediated FoxP3 induction 
  To investigate the capacity of diff  erent APC subsets to induce 
A-Treg generation in vitro, peptide-pulsed splenic CD19     B 
cells and CD11c     DCs were analyzed for their ability to drive 
TGF-    1  –  dependent FoxP3 induction in CD4   OTII    FoxP3        
cells harvested and purifi  ed by sorting from the OTII    FoxP3/
GFP mouse. A diff  erence was observed between these two 
APC subsets to mediate conversion: B cells repeatedly induced 
conversion at rates between 40  –  60%, with DCs inducing 
conversion at substantially lower rates of 0  –  14% (  Fig. 3 A  ; 
and Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20070719/DC1), consistent with a previous study ( 25  ).   
The ability of B cells and DCs to mediate conversion was 
further analyzed by titrating exogenous TGF-    1, further sub-
stantiating the diff  erential capacity of these APC subsets to medi-
ate T reg cell generation (Fig. S1). 
  When the total number of CD4     T cells per well after 
culture was quantifi  ed, DCs generated far more CD4     T cells 
per well then B cells (  Fig. 3 B  ). This was expected, given the 
diff  ering capacities of these APC subsets to activate T cells 
through their diff  erential co-stimulatory molecule expression, 
with DCs far superior at activating CD4     T cells than resting 
B cells (  26  ). We hypothesized that the capacity of APCs to 
activate T cells through co-stimulatory molecule expression, 
such as CD80/86, is inversely correlated with their ability to 
support the generation of A-Tregs. By extension of this 
hypothesis, the greater the absolute yield of daughter T cells 
generated by an APC, the fewer the number of FoxP3-
expressing T cells. To test this hypothesis directly, we examined 
the ability of CD80/86 knockout splenic DCs and B cells 
and IL-2 under activating conditions would generate cells 
with a CD4    FoxP3        4    7    CCR9     phenotype. We sorted 
CD4    FoxP3        cells from the FoxP3/GFP reporter mouse to 
  >  99.9% purity, using this approach throughout the study 
(  20  ). After 5 d of activation by plate-bound     CD3/    CD28 
with TGF-    1, IL-2, and RA, we observed the emergence of 
CD4    FoxP3        4    7    CCR9     T cells (RA  –  T reg cells;   Fig. 
1 A  ).   Concordant with conversion was the induction of CD25, 
a marker for both T reg cells and activated T cells, and the 
expression of CD103, which is induced by TGF-    1 and 
identifi  es an in vivo subset of eff  ector/memory T reg cells, 
which are more potent suppressors than T reg cells lacking 
expression of this molecule (  21  –  23  ). These data show that 
a population bearing the phenotype of a gut-homing T reg cell 
population was generated. Additionally, we observed a   >  90% 
conversion rate of CD4    FoxP3        to CD4    FoxP3     T cells in 
the presence of RA, compared with considerably less in its 
absence (  Fig. 1 B  ). Between experiments, we observed variable 
conversion rates ranging between 15  –  50% in the culture 
conditions of IL-2 and TGF-    1, with the addition of RA 
consistently increasing FoxP3 expression to 90% or greater. 
This synergy between TGF-    1 and RA in inducing FoxP3 
expression could be blocked by the addition of the selec-
tive RA receptor antagonist LE540 (  Fig. 1 C  ). RA was able 
to enhance conversion throughout a titration of TGF-    1, 
although RA, by itself, did not induce conversion. The in-
ability of RA to induce FoxP3 expression without the ad-
dition of exogenous TGF-    1 indicates that conversion was 
exclusively dependent on exogenous TGF-    1 (  Fig. 1 D  ). 
Any endogenous TGF-    1 potentially present within our 
culture medium was unable to mediate this eff  ect. When 
RA was titrated against constant TGF-    1 and IL-2, RA was 
able to enhance TGF-    1  –  dependent conversion even at sub-
nanomolar concentrations (  Fig. 1 E  ). For future experiments 
within this study, unless otherwise indicated, we used 1 nM 
RA in our cultures. This was done for two reasons: fi  rst, at 
concentrations   <  1 nM, the percentage of T cells expressing 
FoxP3 begins to decrease, and second, it has been observed 
that RA has antiproliferative eff  ects on T cells at high con-
centrations (30  –  100 nM RA suppresses T cell proliferation, 
whereas doses   <  5 nM do not; unpublished data) (  24  ). Results 
similar to those shown in   Fig. 1 (A  –  D)   were observed us-
ing 1 nM RA. These data show that RA potently enhances 
TGF-    1  –  dependent FoxP3 induction. 
  The suppressive activity of RA  –  T reg cells was measured 
relative to that of A-Tregs and freshly harvested nTregs in 
an in vitro suppressor assay. The data show that RA  –  T reg 
cells are potent suppressors of T eff  ector cells in vitro (  Fig. 2, 
A and B  ).   It is interesting to speculate that the RA  –  T reg 
cells may even be more potent suppressors of T eff  ector cell 
proliferation, as indicated by their ability to suppress at T reg 
cell/T eff  ector cell ratios that nTregs and A-Tregs could 
not suppress. 
  To examine the in vivo homing capacity of RA  –  T reg 
cells, we performed an in vivo competitive homing experi-
ment (  3, 4  ). RA  –  T reg cells were generated in vitro from a 1768 THE GENERATION OF GUT-HOMING ADAPTIVE T REGULATORY CELLS | Benson et al.
change in the ability of WT B cells versus CD80/86 knock-
out B cells to mediate conversion (63% [SD = 7.81] and 
67.66% [SD = 5.03], respectively), which is expected 
because quiescent B cells express very low basal levels of 
CD80/86 (  26  ). 
to mediate both conversion and T cell expansion. The CD80/86 
knockout DCs were able to induce TGF-    1  –  dependent 
FoxP3 expression in CD4     T cells at a substantially in-
creased rate in comparison with WT DCs (81.33% [SD = 2.31] 
compared with 7.9% [SD = 1.14];   Fig. 3 A  ). There was no 
  Figure 2.     RA  –  T reg cells are suppressive in vitro and home to the small intestine in vivo. To examine the suppressive capacity of A-Tregs, RA  –  T 
reg cells, and nTregs, Ly5.2   Foxp3/GFP    A-Tregs and RA  –  T reg cells were generated in vitro and sorted to   >  99% purity, with Ly5.2     nTregs freshly isolated 
ex vivo from a Ly5.2    Foxp3/GFP reporter mouse. These T reg cell subsets were cultured with CFSE-labeled Ly5.1   CD4    T effector cells at the indicated 
  ratios under activating conditions. Representative CFSE plots of the T effector cells are shown (A), with the percentage of dividing T effector cells quantifi  ed (B). 
(C and D) Representative in vivo competitive homing assay. Naive CD4   Foxp3       cells were sorted from an Ly5.2    Foxp3/GFP reporter mouse and activated 
for 5 d in the presence of TGF-    1, IL-2, and RA to generate RA  –  T reg cells expressing Foxp3/GFP. Naive CD4   CD25       cells were sorted from an Ly5.2    
mouse and cultured under the same conditions, minus the RA, to generate A-Tregs lacking the Foxp3/GFP allele. These two cell populations were mixed 
and injected into recipient mice. (C) Organs were harvested after 18 h and stained for donor Ly5.2   CD4    T cells, and the ratio of GFP  /      cells within the 
donor population was analyzed, with a representative mouse shown. Numbers show the percentage of transfered cells that are FoxP3/GFP     and  FoxP3/GFP  . 
(D) The HI (ration of [GFP   ] tissue /[GFP     ] tissue   to  [GFP  ] input /[GFP     ] input  ) was calculated, with bar graphs showing mean      SEM of one representative 
experiment using three recipient mice. Peripheral lymph node (pLN): HI  0.96 (SEM  0.13); spleen: HI  0.96 (SEM  0.08); blood: HI  0.56 (SEM  
0.05); lung: HI  0.39 (SEM  0.02); mesenteric lymph node (mLN): HI  1.86 (SEM  0.1); Peyer  ’  s patches (PP): HI  3.46 (SEM  0.33); and lamina pro-
pria (LP): HI  12.27 (SEM  0.77). All experiments are representative of at least two independent experiments. *, P   	   0.05; **, P   	   0.01; and ***, P   	   0.001 
compared with HI  1 (dotted line).     JEM VOL. 204, August 6, 2007  1769
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  We next addressed whether B cell activation and the ac-
quisition of heightened co-stimulatory molecule expression 
impaired the ability to induce conversion. When B cells were 
preactivated for 48 h by either LPS or agonistic-    CD40 sup-
plemented with IL-4 and then used as APCs, B cell  –  mediated 
conversion was impaired (  Fig. 3 C  ). 
  When CD4     T cells were activated using WT or CD80/86 
knockout DCs in the presence of exogenous IL-2, con-
siderably more T cells per well were generated by WT 
DCs in comparison with CD80/86 knockout DCs (19.64   
   
10  4   cells [SD = 2.42   
   10  4  ] compared with 9.13   
   10  4   cells 
[SD = 2.48   
   10  4  ];   Fig. 3 B  ). The addition of RA or TGF-    1 
  The in vitro and in vivo activation of both B cells and DCs 
through CD40 engagement by its ligand, CD154, increases 
the expression of CD80/86 by these APCs. The inclusion of 
blocking    CD154 antibody to our co-cultures enabled DCs to 
have an increased ability to mediate conversion (7.94% [SD = 
1.14] compared with 15.26% [SD = 0.55] with     CD154; 
  Fig. 3 A  ). Similar results were observed using CD40 knock-
out DCs (unpublished data). Interestingly,     CD154 antibody 
appeared to decrease B cell  –  mediated conversion, possibly 
implying a requirement for very low levels of co-stimulation 
in this co-culture system (63% [SD = 7.81] compared with 
39.33% [SD = 4.5] with     CD154). 
  Figure 3.     DC expression of CD80/86 co-stimulatory molecules prevents Foxp3 induction by T cells, with exogenous RA overcoming this 
inhibition and allowing T reg cell generation. Sorted CD4   OTII  Foxp3       T cells from the OTII    Foxp3/GFP reporter mouse (100,000 T cells/well) were 
cultured with either purifi  ed WT or CD80/86 knockout CD19     B cells or CD11c     DCs (100,000 APCs/well) pulsed with ISQ peptide, or under activating 
conditions. Media was supplemented with 100 U IL-2,     20 ng/ml TGF-   1,     1 nM RA,    10    g/ml     CD154 (unless otherwise indicated) for 5 d. (A) WT or 
CD80/86 knockout splenic B cells or DCs plus T cells were cultured under the depicted culture conditions, and the percentage of CD4     T cells expressing 
Foxp3/GFP was measured. (B) Same experimental conditions as in A, except with absolute CD4     T cells per well counted, with white bars representing 
CD4   Foxp3       cells and green bars representing CD4   Foxp3    cells. (C) Freshly harvested B cells (quiescent B cells) or 48-h preactivated B cells with the 
  indicated stimulus were co-cultured with T cells, and the percentage of CD4     cells expressing Foxp3/GFP was measured after 5 d. (D) CD4     T cells were 
activated using 10     g/ml of plate-bound     CD3 and titrating concentrations of     CD28, with media supplemented with IL-2 and TGF-   1     10 nM RA as 
indicated; Foxp3/GFP expression was plotted as a function of plate-bound     CD28 concentration. Mean  SEM is depicted in A, B, and D.     1770 THE GENERATION OF GUT-HOMING ADAPTIVE T REGULATORY CELLS | Benson et al.
or both did not aff  ect this observed diff  erence (  Fig. 3 B  ). 
Upon the addition of TGF-    1 to these cultures, the decrease 
of T cell numbers between WT and CD80/86 knockout 
DCs inversely correlated with a substantial increase in the 
number of FoxP3-expressing T cells in the CD80/86 knock-
out group versus the WT group (6.35   
   10  4   cells [SD = 
0.15   
   10  4  ] compared with 1.33   
   10  4   cells [SD = 0.25   
   
10  4  ];   Fig. 3 B  ). 
  The addition of     CD154 did not lead to a considerable 
change in T cell numbers generated by DCs with the addi-
tion of exogenous IL-2 (19.64   
   10  4   [SD = 2.42   
   10  4  ] com-
pared with 11.13   
   10  4   [SD = 7.75   
   10  4  ] with     CD154; 
  Fig. 3 B  ). No diff  erence in T cell number was again observed 
with the further addition of RA or TGF-    1, or both. Addi-
tionally, there was no considerable increase in the numbers of 
FoxP3-expressing cells because of the inclusion of     CD154 
to our DC co-cultures supplemented with TGF-    1 (1.33   
   
10  4   [SD  0.25   
   10  4  ] compared with 1.56   
   10  4   [SD = 0.36   
   
10  4  ];   Fig. 3 B  ). Despite the enhanced conversion imparted 
by     CD154 in our DC/T cell co-cultures in   Fig. 3 A  , this 
result was not entirely unexpected. First, even with a CD154/
CD40 blockade, DCs will still express levels of CD80/86 that 
are suffi   cient in expanding T cells. Second, the increase in DC-
mediated conversion caused by     CD154 may not be enough 
to net an absolute increase in T reg cell numbers in this ex-
perimental system. 
  B cells, CD80/86 knockout B cells, and B cells cultured 
with     CD154 all generated similar total numbers of T cells in 
all culture conditions. This was expected and is likely caused 
by the low levels of co-stimulatory molecule expression on 
the surface of resting B cells (  26  ). Collectively, these data sup-
port our hypothesis that under conditions favoring conver-
sion, the greater the absolute yield of T cells generated by an 
APC and the fewer the number of T cells expressing FoxP3. 
Further substantiating this is our fi  nding that increasing levels 
of plate-bound co-stimulation inversely correlates with the 
absolute number of A-Tregs generated (Fig. S2, available at 
http://www.jem.org/cgi/content/full/jem.20070719/DC1). 
  To directly implicate CD28 as a major mediator aff  ecting 
FoxP3 induction, we varied the magnitude of     CD28 co-
stimulation in an in vitro assay in which plate-bound agonistic 
    CD28 was titrated against saturating concentrations of plate-
bound     CD3. It was observed that     CD28 concentration had 
an inverse relationship with A-Treg generation, with optimal 
conversion occurring at     CD28 concentrations of 1     g/ml 
and below. At saturating concentrations (10     g/ml     CD28), 
no conversion was observed (  Fig. 3 D  ). Collectively, these data 
show that high levels of CD80/86 co-stimulation, such as those 
observed on splenic CD11c     DCs, impairs TGF-    1  –  driven 
FoxP3 induction and A-Treg generation while inducing 
  Figure 4.     RA enhances Foxp3 expression without impeding T cell 
activation and proliferation. Purifi  ed CFSE-labeled CD4   CD25       T  cells 
from a WT B6 mouse were cultured with IL-2, TGF-    1, and 1 nM RA, as 
indicated, under activating conditions for 4 d, after which CD62L and 
Foxp3 expression was measured. (A) CFSE dye dilution versus CD62L 
  expression is shown, with T cells cultured with IL-2 or IL-2 plus 1 nM RA 
under different activating conditions. The percentage of T cells within 
each quadrant is depicted. (B) Histograms depicting CFSE dye dilution 
profi  les of the data shown in A (IL-2, blue; IL-2 with 1 nM RA, red). 
(C) CFSE dye dilution versus Foxp3 expression is shown with the indicated 
activating and culture conditions, with the percentage of cells in each quad-
rant shown. Representative experiments of at least   n    3 mice are shown.    JEM VOL. 204, August 6, 2007  1771
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the presence of RA (  Fig. 4 C  ). Importantly, RA enhances 
TGF-    1  –  mediated FoxP3 expression in the absence of any 
    CD28 signal and just the presence of     CD3 (  Fig. 4 C 
and Fig. 3 D  ). Collectively, these data show that RA enhances 
FoxP3 induction and attenuates co-stimulation from inter-
fering with T reg cell generation through a mechanism in-
dependent of dampening T cell activation and proliferation. 
Fur  thermore, co-stimulation is not needed for RA to enhance 
FoxP3 induction. 
  RA  –  T reg cells are refractory to reversion in vivo 
  RA is known to induce diff  erentiation in a variety of primary 
and tumor cell types. As such, we addressed whether RA  –  T 
maximal expansion of T cells. In the context of minimal to 
no CD80/86 co-stimulation, such as levels present on resting 
B cells and CD80/86 knockout DCs, little to no expansion 
occurs, with TGF-    1  –  dependent FoxP3 expression and T reg 
cell generation the result. 
  The addition of RA to our assays greatly enhanced both 
the percentage and total numbers of T cells expressing FoxP3 
in a TGF-    1  –  dependent manner (  Fig. 3, A and B  ; Fig. S1; 
and Fig. S2). Notably, the addition of RA to our DC/T cell 
co-cultures increased the percentage of T cells expressing 
FoxP3 from 7.94% (SD = 1.14) to 72% (SD = 2;   Fig. 3 A  ). 
Additionally, the combination of RA with TGF-    1 resulted 
in a net increase in the numbers of FoxP3-expressing cells in 
all DC cultures in comparison with TGF-    1 alone (WT 
DCs: from 1.33   
   10  4   [SD = 0.25   
   10  4  ] to 9.96   
   10  4   [SD  
0.62   
   10  4  ]; CD80/86 knockout DCs: from 6.35   
   10  4   
[SD = 0.15   
   10  4  ] to 8.7   
   10  4   [SD = 0.19   
   10  4  ]; DCs with 
    CD154: from 1.56   
   10  4   [SD = 0.36   
   10  4  ] to 9.9   
   10  4   
[SD = 0.19   
   10  4  ];   Fig. 3 B   and Fig. S1). Furthermore, RA 
reversed co-stimulation from suppressing, in dose-dependent 
manner, the net yield of FoxP3     T cells, as concentrations of 
plate-bound     CD28 now positively correlate with FoxP3     
T cell numbers (Fig. S2). Across all concentrations of plate-
bound     CD28, as well as in the presence of only a TCR sig-
nal with no     CD28, RA greatly enhanced the percentage 
of T cells expressing FoxP3 (  Fig. 3 D  ). In this experiment, 
co-stimulation still aff  ected FoxP3 induction in a dose-
dependent manner, albeit to a substantially attenuated degree, 
as a result of the inclusion of RA. This suggests that RA low-
ers an as yet undefi  ned threshold within the T cell, with this 
threshold determining whether the T cell can convert into a 
T reg cell. Thus, the presence of RA during antigen presen-
tation allows TGF-    1  –  dependent FoxP3 induction to occur 
by T cells, even in the face of overt CD80/86 co-stimulation 
aff  orded by the DC. 
  RA enhances FoxP3 expression without impeding T cell 
activation and proliferation 
  The observation that RA  –  T reg cells can be induced in the 
presence of high levels of co-stimulation led us the question 
whether this occurs by RA functioning to interrupt T cell 
activation and proliferation. To visualize this, CFSE-labeled 
CD4    CD25        cells were stimulated in the presence and ab-
sence of 1 nM RA, with T cell activation determined by 
CD62L expression and proliferation by CFSE dye dilution. 
The data shows that 1 nM RA does not suppress T cell ac-
tivation, as indicated by CD62L expression. Instead, RA 
appears to enhance T cell activation, as indicated by the 
decreased expression of CD62L across the three levels of 
activating conditions tested (  Fig. 4 A  ).   Additionally, when 
CFSE histograms between diff  erent culture conditions are 
overlaid, equivalent profi  les indicate that the addition of 
RA does not impede T cell proliferation (  Fig. 4 B  ). The ad-
dition of TGF-    1 to these cultures generated FoxP3     cells 
at expected frequencies throughout all peaks of cell division, 
with no impediment in cell division observed because of 
  Figure 5.     RA  –  T reg cells are refractory to reversion in vivo. The 
ability of RA  –  T reg cells and A-Tregs to revert in vivo was analyzed by 
transferring  1.5 – 2   
   10 6   FACS-sorted congenically marked OTII     RA – T  reg 
cells or A-Tregs generated from a Ly5.2   OTII   Foxp3/GFP mice into Ly5.1    
hosts, who were either left untouched or intraperitoneally injected on the 
same day with either CFA or 1 mg OVA/CFA, as indicated. Donor RA  –  T reg 
cells or A-Tregs within the spleen were analyzed for Foxp3 expression on 
day 5 by staining for CD4   Ly5.2    cells. RA  –  T reg cells are red, whereas 
A-Tregs are black (A). Horizontal lines represent the means. To examine 
relative donor T cell expansion 5 d after transfer, the percentage of donor 
OTII     cells within the recipient splenic CD4     compartment is shown in 
a box and whisker plot depicting the median, 25th, and 75th percentiles 
and range of values (B). Data are pooled from   n    3 independent 
experiments.  ***,  P   <   0.001.   1772 THE GENERATION OF GUT-HOMING ADAPTIVE T REGULATORY CELLS | Benson et al.
tolerance through RA  –  T reg cell induction. Finally, with the 
use of A-Tregs in cellular adoptive therapies on the horizon, 
the use of RA in vitro to facilitate the production of fully 
committed, gut-homing A-Tregs is an attractive technology to 
meet the needs for high numbers of these cells in the therapeutic 
treatment of autoimmune disorders such as infl  ammatory 
bowel disease. 
  MATERIALS AND METHODS 
  Mice and immunizations.     This study was approved by the Institutional 
Animal Care and Use Committee of Dartmouth College. C57BL/6 and 
C57BL/6 CD45.1 (Ly5.2    ) mice were purchased from the National Can-
cer Institute. C56BL/6 CD40      /      mice were purchased from the Jackson 
Laboratory. FoxP3/GFP reporter mice were previously described and were 
provided by A. Rudensky (University of Washington School of Medicine, 
Seattle, WA) (  20  ). FoxP3/GFP mice were bred onto OTII TCR-Tg mice 
purchased from the Jackson Laboratory. CD80/86 double knockout mice 
on the C57BL/6 background were a gift from E. Usherwood (Dartmouth 
Medical School, Lebanon, NH). All animals were maintained in a pathogen-
free facility at Dartmouth Medical School. For immunizations, OVA 
(Sigma-Aldrich) resuspended in PBS or PBS alone was emulsifi  ed in CFA 
(Sigma-Aldrich) at a 1:1 ratio and intraperitoneally injected in a volume 
of 200     l. 
  Cell preparation.     B cells and DCs were harvested from the spleens, and 
CD4    FoxP3        cells were isolated from spleens and peripheral and mesen-
teric lymph nodes. For B cell and T cells, single-cell suspensions were gen-
erated by crushing organs by sterile slides and were purifi  ed by positive 
selection using either     CD4- or     CD19-labeled magnetic beads (Miltenyi 
Biotec). T cells were further purifi  ed by FACS sorting (FACSAria; BD 
Biosciences) of the CD4FoxP3/GFP        fraction, with purity always   >  99.9%. 
For CD11c     selection, spleens were harvested and incubated at 37  °  C 
in RPMI 1640 with 50     g/ml DNase I (Sigma-Aldrich) and 250     g/ml 
Liberase (Roche) for 30 min, pushed through a 100-    M fi  lter to create a 
single-cell suspension, and purifi  ed using     CD11c magnetic beads (Miltenyi 
Biotec). Cell preparations were always   >  98% in purity. For small intestine 
lamina propria lymphocyte preparations, intestines were removed, and 
Peyer  ’  s Patches were excised and used for further analysis. The intestines 
were washed with cold PBS, split open, and cut into 1-cm pieces. After 
30 min of incubation in unsupplemented RPMI to release the intestinal 
epithelial lymphocytes, intestines were vortexed, fi  ltered using a 100-    M 
fi  lter, and extensively washed. Intestines were digested for 2 h using 50     g/ml 
DNase I and 250     g/ml Liberase, after which they were pushed through a 
100-    M fi  lter. The cellular suspension was centrifuged and suspended in 
40% Percoll, and overlaid on 60% Percoll. The Percoll gradient was spun at 
400   g   at room temperature for 25 min with no brake, with the buff  y (lym-
phocyte) coat removed for further use. As indicated in the fi  gures, APCs 
were pulsed with ISQ peptide at 10     g/ml for 1 h in cRPMI in sixwell 
plates at a concentration of 10   
   10  6   cells/ml, and were washed, counted, 
and used. 
  Cell culture/reagents.     Cells were cultured in RPMI 1640 media sup-
plemented with 10% FBS (Atlanta Biologicals), Hepes, 50     M     -ME, and 
penicillin/streptomycin/  l  -glutamine. LPS was purchased from Sigma-Aldrich. 
    CD40 (clone FGK-45),     CD154 (clone MR1),     CD28 (clone PV-1), and 
    CD3 (clone 2C11) were purchased from ISC BioExpress. LE540 was 
purchased from Wako Chemicals. For 96-well plate cultures, 200,000 cells 
in APC/T cell co-cultures (1:1 ratio) in round-bottom plates or 100,000 
T cells in fl  at-bottom plates were cultured in 200     l of media. In each ex-
periment, triplicate wells of each experimental condition were set up. For 
the bulk RA  –  T reg cell and A-Treg cultures in   Fig. 2 and Fig. 5  , 24-well 
fl  at-well plates were used with 100,000 CD4    FoxP3        cells/well in 1 ml of 
reg cells were more committed to the T reg cell lineage and 
less prone to revert to FoxP3    −    T cells then A-Tregs in vivo. 
To examine the propensity of A-Tregs and RA  –  T reg cells 
to revert under diff  erent in vivo conditions, these cells were 
generated from Ly5.2    OTII    FoxP3/GFP reporter mice, sorted 
to   >  99.9% FoxP3    , and transferred into Ly5.1     recipients. 
Hosts were either unmanipulated, or immunized with OVA/
CFA or PBS/CFA (  Fig. 5 A  ).   After 5 d, the transferred cells 
were analyzed for FoxP3 expression. Very few (9%) RA  –  T 
reg cells lost FoxP3 expression in both the unmanipulated or 
CFA only mice, indicating stability in RA  –  T reg cell diff  er-
entiation even in the presence of infl  ammation. Surprisingly, 
a much larger percentage of A-Tregs lost FoxP3 expression 
in both unmanipulated and CFA only treated mice (40%) 
when compared with RA  –  T reg cells in similarly treated 
mice (9%). When injected with OVA/CFA, the frequency of 
FoxP3     cells was reduced in both RA  –  T reg cell and A-Treg 
populations at similar rates. As expected, these CD4    OTII     
cells expanded within the recipients upon antigen injection 
(  Fig. 5 B  ). In conclusion, RA  –  T reg cells were more refractory 
to reversion then A-Tregs under unmanipulated and infl  am-
matory conditions, yet antigen encounter with infl  ammation 
drove partial reversion in both groups. 
  The data presented in this report shows that RA is a 
powerful inducer of FoxP3 expression and enhances commit-
ment to the T reg cell lineage. The inclusion of RA during 
the generation of A-Tregs (a) imprints a gut-homing capacity, 
(b) allows FoxP3 induction in the presence of high levels 
of co-stimulation by attenuating the inhibitory impact of co-
stimulation on FoxP3 induction, (c) increases the frequency 
and total numbers of FoxP3     T cells, and (d) induces T reg 
cells that are more refractory to reversion in vivo. Addition-
ally, we implicate CD80/86 expression by APCs as a major 
mediator of A-Treg generation, as graded ligation of CD28 
on the CD4     T cell surface has an inverse relationship with 
the capacity of that T cell to express FoxP3 in a TGF-    1  –
  dependent manner. Collectively, these data underscore the 
potentially overwhelming impact of DCs producing RA 
within the gut on the fate of activated T cells. Despite their 
propensity to mediate A-Treg generation, it is unlikely that 
B cells contribute to dual gut imprinting and A-Treg gen-
eration. Unlike gut-derived DCs, B cells harvested from 
the spleen, Peyer  ’  s patches, or mesenteric lymph nodes do 
not imprint a gut-homing phenotype on CD4     T cells (un-
published data). Because of this, B cells are not likely to secrete 
RA in vivo. 
  The implications of these data are important. First, Powrie 
et al. and Agace et al. jointly described CD103    CD11c     
DCs present within the mesenteric lymph nodes, Peyer  ’  s 
Patches, and small and large bowel lamina propria as composing 
the DC subset responsible for mediating gut imprinting of 
T cells through CCR9 and     4    7 induction. Second, these 
CD103     DCs likely imprint through an RA-dependent 
mechanism, although this has not yet been directly shown 
(  9, 10  ). Therefore, our data suggest a new role for RA in 
mediating not only gut imprinting but also in driving gut JEM VOL. 204, August 6, 2007  1773
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media. For all cultures, unless indicated otherwise in the fi  gures, T cells were 
activated with 1     g/ml     CD28 and 10     g/ml     CD3 plate-bound antibody in 
the presence of 20 ng/ml hTGF-    1 (PeproTech), 100 U hIL-2 (PeproTech), 
and RA (Sigma-Aldrich). For the in vitro suppressor assay, 50,000 CFSE-labeled 
CD4     T cells were co-cultured with 100,000 irradiated T cell  –  depleted 
splenocytes, 5     g/ml     CD3, and the numbers of T reg cells indicated in the 
fi  gures for 4 d, as previously described (  27, 28  ). For   Fig. 3   and Fig. S2, cells 
were counted by Guava according to instructions provided by the manufac-
turer (Guava Technologies) 
  Flow cytometry.     The following antibodies were used: CD11c (clone 
N418), CD25 (clone PC61), and CD62L (clone MEL-14; all obtained from 
BioLegend); B220 (clone 6B2), CD4 (clone L3T4), and      4        7   (clone DATK32; 
all obtained from BD Biosciences); CCR9 (clone 242503; obtained from 
R  &  D Systems); and CD103 (clone 2E7) and the FoxP3 intracellular staining 
kit (obtained from eBioscience). For CFSE dye dilution, cells were labeled 
with 5     M CFSE (Invitrogen). Flow cytometric analysis was performed on 
a refurbished machine (FACScan; Becton Dickinson) running CellQuest 
software (BD Biosciences), and data analysis was performed using FlowJo 
software (TreeStar, Inc.). 
  Homing assay.     Competitive homing experiments of RA  –  T reg cells and 
A-Tregs were performed as previously described, with modifi  cations (  3  ). In 
brief, 10   ×   10  6   RA  –  T reg cells generated from sorted CD4    FoxP3        cells 
purifi  ed from a Ly5.2    FoxP3/GFP reporter mouse were mixed with an 
approximately equal number of A-Tregs generated from FACS-sorted 
CD4    CD25        cells harvested from a Ly5.2     mouse (determined to be     20% 
FoxP3    , as gauged by intracellular FoxP3 staining) and intravenously in-
jected into Ly5.1     C57BL/6 mice. An aliquot was saved to determine the 
input ratio: IR = (GFP    )  input  /(GFP       )  input  ). The homing index (HI) was cal-
culated as the ratio of (GFP    )  tissue  /(GFP       )  tissue   to IR. Homing indices were 
tested versus HI = 1 using a one-sample Wilcoxon signed-rank test. Signifi  -
cance was set at P   <   0.05. 
  Online supplemental material.     Fig. S1 shows that DCs, with the addition 
of exogenous RA, can induce FoxP3 expression in T cells in a TGF-    1  –
  dependent manner and over a dose titration of TGF-    1. Fig. S2 shows that 
the addition of exogenous RA to TGF-    1 and IL-2 induces a net increase in 
the total number of T reg cells generated under various levels of plate-bound 
co-stimulation. Online supplemental material is available at http://www
.jem.org/cgi/content/full/jem.20070719/DC1. 
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